Australian Cardiac Outcomes Registry of Transcatheter Aortic Valve Implantation: Report and Update of Transcatheter Aortic Valve Implantation in Australia

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart, Lung and Circulation Pub Date : 2025-05-01 DOI:10.1016/j.hlc.2025.02.107

Ajay Sinhal FRACP FCSANZ , Jayme Bennetts FRACS FCSANZ , Ravinay Bhindi FRACP FCSANZ , Kara Cashman MSc , Anita Deakin MSc , Robert Gooley FRACP FCSANZ , Emma Heath MSc , Michelle Lorimer PhD , David Muller FRACP FCSANZ , Martin Ng FRACP FCSANZ , Ross Roberts-Thomson FRACP FCSANZ , Darren Walters FRACP FCSANZ , Antony Walton FRACP FCSANZ , Robert Whitbourn FRACP FCSANZ , William Wilson FRACP FCSANZ , Gerald Yong FRACP FCSANZ , Anthony Camuglia FRACP FCSANZ

{"title":"Australian Cardiac Outcomes Registry of Transcatheter Aortic Valve Implantation: Report and Update of Transcatheter Aortic Valve Implantation in Australia","authors":"Ajay Sinhal FRACP FCSANZ , Jayme Bennetts FRACS FCSANZ , Ravinay Bhindi FRACP FCSANZ , Kara Cashman MSc , Anita Deakin MSc , Robert Gooley FRACP FCSANZ , Emma Heath MSc , Michelle Lorimer PhD , David Muller FRACP FCSANZ , Martin Ng FRACP FCSANZ , Ross Roberts-Thomson FRACP FCSANZ , Darren Walters FRACP FCSANZ , Antony Walton FRACP FCSANZ , Robert Whitbourn FRACP FCSANZ , William Wilson FRACP FCSANZ , Gerald Yong FRACP FCSANZ , Anthony Camuglia FRACP FCSANZ","doi":"10.1016/j.hlc.2025.02.107","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Transcatheter aortic valve implantation (TAVI) procedures performed in Australia are recorded in the national Australian Cardiac Outcomes Registry (ACOR) TAVI Registry. Characteristics of patients and operators are prospectively collected with reference to patient demographics, procedural factors as well as outcomes related to both efficacy and safety metrics.</div></div><div><h3>Methods</h3><div>Patient level data reported to the ACOR TAVI Registry from enrolled sites from registry inception up until 31 December 2021 were analysed. Key safety and efficacy metrics were identified and used to assess TAVI performance and outcomes in the Australian setting.</div></div><div><h3>Results</h3><div>From 10 April 2018 to 31 December 2021, 9,881 consecutive patients underwent a TAVI procedure in Australia across 42 TAVI hospitals. The mean age of patients treated was 81.8 years (± standard deviation [SD] 7.1 years), 40.6% were female and the mean STS (Society for Thoracic Surgeons) score was 5.3% (±SD 4.4%). Overall, 0.3% of the cohort identified as Australian Aboriginal or Torres Strait Islander peoples. All-cause mortality at 30 days and 12 months was 1.37% and 5.57% respectively. The 30-day rates of stroke, major vascular complications and newly implanted permanent pacemaker were 2.19%, 1.23% and 10.68% respectively. There were 181 unique primary operators who performed TAVI during this time with an annualised median number of 19 procedures per operator per year (interquartile range [IQR] 42.5) and 63% of operators performed <30 cases per year.</div></div><div><h3>Conclusions</h3><div>TAVI is being performed in Australia with the encouraging outcomes described. These would appear to compare favourably with other international datasets.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 5","pages":"Pages 472-484"},"PeriodicalIF":2.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart, Lung and Circulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1443950625001714","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Transcatheter aortic valve implantation (TAVI) procedures performed in Australia are recorded in the national Australian Cardiac Outcomes Registry (ACOR) TAVI Registry. Characteristics of patients and operators are prospectively collected with reference to patient demographics, procedural factors as well as outcomes related to both efficacy and safety metrics.

Methods

Patient level data reported to the ACOR TAVI Registry from enrolled sites from registry inception up until 31 December 2021 were analysed. Key safety and efficacy metrics were identified and used to assess TAVI performance and outcomes in the Australian setting.

Results

From 10 April 2018 to 31 December 2021, 9,881 consecutive patients underwent a TAVI procedure in Australia across 42 TAVI hospitals. The mean age of patients treated was 81.8 years (± standard deviation [SD] 7.1 years), 40.6% were female and the mean STS (Society for Thoracic Surgeons) score was 5.3% (±SD 4.4%). Overall, 0.3% of the cohort identified as Australian Aboriginal or Torres Strait Islander peoples. All-cause mortality at 30 days and 12 months was 1.37% and 5.57% respectively. The 30-day rates of stroke, major vascular complications and newly implanted permanent pacemaker were 2.19%, 1.23% and 10.68% respectively. There were 181 unique primary operators who performed TAVI during this time with an annualised median number of 19 procedures per operator per year (interquartile range [IQR] 42.5) and 63% of operators performed <30 cases per year.

Conclusions

TAVI is being performed in Australia with the encouraging outcomes described. These would appear to compare favourably with other international datasets.

查看原文本刊更多论文

澳大利亚经导管主动脉瓣植入术的心脏结果登记：澳大利亚经导管主动脉瓣植入术的报告和更新。

背景：在澳大利亚进行的经导管主动脉瓣植入（TAVI）手术记录在澳大利亚国家心脏结局登记处（ACOR） TAVI登记处。前瞻性地收集患者和操作人员的特征，参考患者人口统计学，程序因素以及与有效性和安全性指标相关的结果。方法：分析从注册开始到2021年12月31日，从入组地点报告给ACOR TAVI Registry的患者水平数据。确定了关键的安全性和有效性指标，并用于评估TAVI在澳大利亚的表现和结果。结果：从2018年4月10日至2021年12月31日，澳大利亚42家TAVI医院连续9881名患者接受了TAVI手术。治疗患者的平均年龄为81.8岁（±标准差[SD] 7.1岁），女性为40.6%，STS（胸外科医师学会）平均评分为5.3%（±SD] 4.4%）。总体而言，0.3%的队列确定为澳大利亚土著或托雷斯海峡岛民。30天和12个月全因死亡率分别为1.37%和5.57%。卒中发生率为2.19%，主要血管并发症发生率为1.23%，新植入永久性起搏器发生率为10.68%。在此期间，有181位独特的主要手术者进行了TAVI手术，每位手术者每年的平均手术数为19例（四分位间距[IQR] 42.5）， 63%的手术者进行了TAVI手术。结论：TAVI正在澳大利亚进行，结果令人鼓舞。这些数据似乎可以与其他国际数据集相比较。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart, Lung and Circulation CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

4.50

自引率

3.80%

发文量

912

审稿时长

11.9 weeks

期刊介绍： Heart, Lung and Circulation publishes articles integrating clinical and research activities in the fields of basic cardiovascular science, clinical cardiology and cardiac surgery, with a focus on emerging issues in cardiovascular disease. The journal promotes multidisciplinary dialogue between cardiologists, cardiothoracic surgeons, cardio-pulmonary physicians and cardiovascular scientists.